Florian Vogl

Florian Vogl is a seasoned medical professional with extensive experience in the pharmaceutical industry. Currently serving as Chief Medical Officer at TOLREMO therapeutics since May 2025, Vogl previously held similar leadership roles at Immutep Limited and Cellestia Biotech from May 2023 to April 2025 and January 2020 to May 2023, respectively. Vogl also contributed as Head of Clinical Development Europe at Rainier Therapeutics and as Sr Global Clinical Leader in Hematology/Oncology at Novartis. Earlier career milestones include positions at Amgen, where Vogl worked as Early Development Leader and Medical Director in Hematology/Oncology, as well as Senior Medical Scientist in International Medical Affairs and Clinical Development.